Search tips
Search criteria 


Logo of jcinvestThe Journal of Clinical Investigation
J Clin Invest. 1985 August; 76(2): 765–769.
PMCID: PMC423897

Cytoplasmic immunoglobulin content in multiple myeloma.


Bone marrow cells of 82 patients with multiple myeloma were subjected to flow cytometric analysis of DNA and cytoplasmic immunoglobulin (CIg) content using propidium iodide and direct immunofluorescence assays. Except for two patients with nonsecretory myeloma, there was conformity in the immunoglobulin type derived from immunoelectrophoresis and plasma cell CIg staining. One patient with nonsecretory myeloma exhibited monotypic CIg staining, while the second showed no reaction. In eight patients with IgG lambda myeloma, the same tumor cells contained both lambda and kappa light chains, suggesting the productive rearrangement of both light chain genes. 14 patients with previously unrecognized plasma cells of low RNA content, all of whom were resistant to chemotherapy, were identified by CIg staining. By revealing previously unrecognized plasma cells with low RNA content, CIg analysis identified more patients with treatment-refractory myeloma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bunn PA, Jr, Krasnow S, Makuch RW, Schlam ML, Schechter GP. Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implications. Blood. 1982 Mar;59(3):528–535. [PubMed]
  • Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Göhde W, Andreeff M, Freireich EJ. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed]
  • Barlogie B, Alexanian R, Gehan EA, Smallwood L, Smith T, Drewinko B. Marrow cytometry and prognosis in myeloma. J Clin Invest. 1983 Sep;72(3):853–861. [PMC free article] [PubMed]
  • Barlogie B, Smith L, Alexanian R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med. 1984 May 24;310(21):1353–1356. [PubMed]
  • Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed]
  • Barlogie B, Latreille J, Freireich EJ, Fu CT, Mellard D, Meistrich M, Andreeff M. Characterization of hematologic malignancies by flow cytometry. Blood Cells. 1980;6(4):719–744. [PubMed]
  • Crissman HA, Mullaney PF, Steinkamp JA. Methods and applications of flow systems for analysis and sorting of mammalian cells. Methods Cell Biol. 1975;9(0):179–246. [PubMed]
  • Anderson KC, Park EK, Bates MP, Leonard RC, Hardy R, Schlossman SF, Nadler LM. Antigens on human plasma cells identified by monoclonal antibodies. J Immunol. 1983 Mar;130(3):1132–1138. [PubMed]
  • Ruiz-Argüelles GJ, Katzmann JA, Greipp PR, Gonchoroff NJ, Garton JP, Kyle RA. Multiple myeloma: circulating lymphocytes that express plasma cell antigens. Blood. 1984 Aug;64(2):352–356. [PubMed]
  • Zeile G. Intracytoplasmic immunofluorescence in multiple myeloma. Cytometry. 1980 Jul;1(1):37–41. [PubMed]
  • Bouvet JP, Buffe D, Oriol R, Liacopoulos P. Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies. Immunology. 1974 Dec;27(6):1095–1101. [PubMed]
  • Hopper JE. Comparative studies on monotypic IgM lambda and IgG kappa from an individual patient. IV. Immunofluorescent evidence for a common clonal synthesis. Blood. 1977 Aug;50(2):203–211. [PubMed]
  • Choi YJ, Wong MS. Double light-chain production by leukemic cells of common clonal origin: a case report with review of pertinent literature. Am J Hematol. 1981;11(1):93–98. [PubMed]
  • Korsmeyer SJ, Hieter PA, Ravetch JV, Poplack DG, Waldmann TA, Leder P. Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci U S A. 1981 Nov;78(11):7096–7100. [PubMed]
  • Hieter PA, Korsmeyer SJ, Waldmann TA, Leder P. Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells. Nature. 1981 Apr 2;290(5805):368–372. [PubMed]
  • Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727–1733. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation